Portugal starts vaccination campaign against COVID-19 - People s Daily Online en.people.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.people.cn Daily Mail and Mail on Sunday newspapers.
Source: Xinhua|
Editor: huaxia
Video PlayerClose
LISBON, Dec. 28 (Xinhua) Portugal began its vaccination campaign against COVID-19 on Sunday, with the first batch of 9,750 doses of vaccines developed by Pfizer-BioNTech being administered to health professionals at hospitals in the cities of Porto, Coimbra and Lisbon.
This moment symbolizes the ability to work together, because for months the professionals of the National Health Service and other sectors of society have been collaborating to guarantee the best care and the best assistance, said Health Minister Marta Temido, who was visiting and monitoring various vaccination sites.
The first vaccination phase will last until the end of March 2021, with 1.2 million free doses expected to be applied, health authorities said, adding that nursing homes are the next priority group for vaccination.
Feature: Portugal starts vaccination campaign against COVID-19 china.org.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from china.org.cn Daily Mail and Mail on Sunday newspapers.
Portugal began its vaccination campaign against COVID-19 on Sunday, with the first batch of 9,750 doses of vaccines developed by Pfizer-BioNTech being administered to health professionals at hospitals in the cities of Porto, Coimbra and Lisbon.
This moment “symbolizes the ability to work together, because for months the professionals of the National Health Service and other sectors of society have been collaborating to guarantee the best care and the best assistance,” said Health Minister Marta Temido, who was visiting and monitoring various vaccination sites.
The first vaccination phase will last until the end of March 2021, with 1.2 million free doses expected to be applied, health authorities said, adding that nursing homes are the next priority group for vaccination.
Credit: IRB Barcelona
T-cell acute lymphoblastic leukaemia (T-ALL) is a cancer of the blood that affects mainly children, but also less frequently adults. In adults, although the response to treatment might be initially positive, relapses are common and have a poor prognosis.
A collaborative project between IRB Barcelona s Biomedical Genomics lab, headed by ICREA researcher Núria López-Bigas, Anna Bigas group at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar), and Josep Maria Ribera s lab at the Josep Carreras Leukaemia Research Institute (IJC) has discovered that the cells responsible for resistance to T-ALL treatment in adults are already present in the tumours before diagnosis.